Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
AllStar Pro hypod insulin inj pen reusable for 3ml cartridge 1 unit dial up / range 1-80 units blue
21010900915
|
AllStar Pro hypod insulin inj pen reusable for 3ml cartridge 1 unit dial up / range 1-80 units blue | Other Appliances | Appliances | 904 |
|
Appeel Sterile medical adhesive remover wipes
21360000101
|
Appeel Sterile medical adhesive remover wipes | Adhesive Dressing Remover Ster Silicone | Appliances | 904 |
|
SunVit-D3 3,000unit tablets
0906040G0BWAGAC
|
SunVit-D3 | Colecalciferol | Nutrition and Blood | 904 |
|
Xylometazoline 0.05% nasal drops
1202020P0AAAAAA
|
Xylometazoline hydrochloride | Xylometazoline hydrochloride | Ear, Nose and Oropharynx | 904 |
|
Frumil LS 20mg/2.5mg tablets
0202040B0BBABAB
|
Frumil (Systemic) | Co-amilofruse (Amiloride hydrochloride/frusemide) | Cardiovascular System | 903 |
|
Bimizza 150microgram/20microgram tablets
0703010E0BQAAAB
|
Bimizza | Combined ethinylestradiol 20mcg | Obstetrics, Gynaecology and Urinary-Tract Disorders | 902 |
|
Nutrison Protein Shot liquid
0914051A0BCAAAB
|
Nutrison tube feed additive 1 kcal/ml higher protein liquid | Tube feed additive 1 kcal/ml higher protein liquid (0914051) | Nutrition and Blood | 902 |
|
Pancrex V capsules
0109040N0BBABAG
|
Pancrex | Pancreatin | Gastro-Intestinal System | 902 |
|
Lanthanum carbonate 1g chewable tablets
0905022T0AAACAC
|
Lanthanum carbonate | Lanthanum carbonate | Nutrition and Blood | 901 |
|
SenSura Mio urostomy bag maxi transparent 10-45mm
23961009683
|
SenSura Mio urostomy bag maxi transparent 10-45mm | Urostomy Bags | Stoma Appliances | 901 |
|
Minims saline 0.9% eye drops 0.5ml unit dose
1108010K0BBAAAY
|
Minims sodium chloride | Sodium chloride | Eye | 900 |
|
Calcium folinate 15mg tablets
0801000I0AAAHAH
|
Calcium folinate (Antimetabolite) | Calcium folinate | Malignant Disease and Immunosuppression | 899 |
|
Vimpat 50mg tablets
0408010AHBBAAAA
|
Vimpat | Lacosamide | Central Nervous System | 899 |
|
Levodopa 100mg / Carbidopa 25mg / Entacapone 200mg tablets
0409010X0AAABAB
|
Levodopa/carbidopa/entacapone | Levodopa/carbidopa/entacapone | Central Nervous System | 898 |
|
Melatonin 10mg/5ml oral suspension
0401010ADAACECE
|
Melatonin | Melatonin | Central Nervous System | 898 |
|
Mirvaso 3mg/g gel
1306030A0BBAAAA
|
Mirvaso | Brimonidine tart (Rosacea) | Skin | 898 |
|
Paroxetine 10mg/5ml oral suspension sugar free
0403030P0AAAGAG
|
Paroxetine hydrochloride | Paroxetine hydrochloride | Central Nervous System | 898 |
|
Aciclovir 400mg/5ml oral suspension sugar free
0503021C0AAAFAF
|
Aciclovir (Systemic) | Aciclovir | Infections | 897 |
|
Mepilex Border Lite dressing 10cm x 10.5cm
20030900343
|
Mepilex Border Lite dressing 10cm x 10.5cm | Wound Management & Other Dressings | Dressings | 897 |
|
GlucoRx Dual-Safe Pen insulin needles for pf / reusable pen injectors screw on 5mm/31gauge
21012600165
|
GlucoRx Dual-Safe Pen insulin needles for pf / reusable pen injectors screw on 5mm/31gauge | Other Appliances | Appliances | 896 |
|
Zomorph 200mg modified-release capsules
0407020Q0BKAEEI
|
Zomorph | Morphine sulfate | Central Nervous System | 896 |
|
Zonisamide 100mg/5ml oral suspension
0408010ADAAAGAG
|
Zonisamide | Zonisamide | Central Nervous System | 895 |
|
NephSys belt adult
22702957011
|
NephSys belt adult | Suspensory Systems | Incontinence Appliances | 894 |
|
Oramorph 20mg/ml concentrated oral solution
0407020Q0BCABA6
|
Oramorph | Morphine sulfate | Central Nervous System | 894 |
|
AlfacalEss 0.25microgram capsules
0906040B0BCAAAA
|
AlfacalEss | Alfacalcidol | Nutrition and Blood | 893 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.